Evidence map›Paper›PMID 41647419›Full record

ArticleRSC advances2026

Novel pyridine-heterocycle hybrids: synthesis

Hadeer M Diab, Mostafa E Salem, Ahmed H M Elwahy, Mohamed A Ragheb, Mahmoud A Noamaan, Faisal K Algethami, Ismail A Abdelhamid, Huda Kamel Mahmoud

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hadeer M DiabDepartment of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt aelwahy@hotmail.com aelwhy@cu.edu.eg ismail_shafy@yahoo.com ismail_shafy@cu.edu.eg.
Mostafa E SalemChemistry Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU) P.O. Box 90905 Riyadh 11623 Saudi Arabia.ORCID https://orcid.org/0000-0003-4341-410X
Ahmed H M ElwahyDepartment of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt aelwahy@hotmail.com aelwhy@cu.edu.eg ismail_shafy@yahoo.com ismail_shafy@cu.edu.eg.ORCID https://orcid.org/0000-0002-3992-9488
Mohamed A RaghebDepartment of Chemistry (Biochemistry Division), Faculty of Science, Cairo University Giza 12613 Egypt.
Mahmoud A NoamaanDepartment of Mathematics, Faculty of Science, Cairo University Giza 12613 Egypt.
Faisal K AlgethamiChemistry Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU) P.O. Box 90905 Riyadh 11623 Saudi Arabia.ORCID https://orcid.org/0000-0003-4280-1538
Ismail A AbdelhamidDepartment of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt aelwahy@hotmail.com aelwhy@cu.edu.eg ismail_shafy@yahoo.com ismail_shafy@cu.edu.eg.ORCID https://orcid.org/0000-0003-1220-8370
Huda Kamel MahmoudDepartment of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt aelwahy@hotmail.com aelwhy@cu.edu.eg ismail_shafy@yahoo.com ismail_shafy@cu.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a serious global health issue and remains one of the top causes of death worldwide. To overcome the problems of the existing anticancer drugs in terms of specificity and resistance, a new class of hybrid bis-heterocyclic compounds with a pyridine bridge has been designed and synthesized

Identifiers

PMID41647419
PMCPMC12869285

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.